Stifel Reiterates Buy Rating. $12 PT on Equillium (EQ), Believes Phase 3 Study is "An Important Stepping Stone in Unlocking Pipeline Potential"
Tweet Send to a Friend
Stifel analyst Dae Gon Ha reiterated a Buy rating and $12.00 price target on Equillium (NASDAQ: EQ), following company's announcement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
